维普期刊资源整合服务平台（V6.5）

151篇 您的检索式：作者名="Bookman MA"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of monoclonal humanized anti-HER2 antibody,trastuzumab,in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2:a phase II trial of the Gynecologic Oncology Group显示文摘	Bookman MA Darcy KM Clarke-Pearson D	2003	J Clin Oncol2003，21，2：	1
2	Incorporation of bevacizumab in the primary treatment of ovarian cancer 显示文摘	Burger RA Brady MF Bookman MA	2011	N Engl JMed2011，365，26：	1
3	Gemcitabine monotherapy in recurrent ovarian cancer:from the bench to the clinic显示文摘	Bookman MA	2005	Int J Gynecol Cancer2005，15，1：	1
4	Focus on epithelial ovarian cancer 显示文摘	Ozols RF Bookman MA Cormolly DC	2004	Cancer Cell2004，5，1：	1
5	Carboplatin and paclitaxel in ovarian carcinoma: a phase Ⅰ study of the Gynecologic Oncology Group 显示文摘	Bookman MA McGuire WP Ⅲ Kilpatrick D	1996	J Clin Oncol1996，14，：	1
6	Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer:a Phase III Trial of the Gynecologic Cancer Intergroup显示文摘	Bookman MA Brady MF McGuire WP		0，，：	1
7	Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers显示文摘	Edge SB Niland JC Bookman MA	2003	J Nail Cancer Inst2003，95，20：	1
8	Developmental chemotherapy in advanced ovarian cancer:incorporation of newer cytotoxic agents in a phase Ⅲ randomized trial of the Gynecologic Ocology Group(GOG 0182)显示文摘	Bookman MA	2002	Semin Oncol2002，29，4：	1
9	Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: a GOG study 显示文摘	McGuire WP Blessing JA Bookman MA	2000	J Clin Oncol2000，18，5：	1
10	Incorporation of bevacizumab in the primary treatment of ovarian cancer显示文摘	Burger RA Brady MF Bookman MA	2011	New Engl J Med2011，365，26：	1
11	A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors 显示文摘	Posey JA Khazaeli MB Bookman MA	2002	Clin Cancer Res2002，8，10：	1
12	Topotecan for the treatment of advanced epithelial ovarian cnacer: an open-label phase Ⅱ study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel 显示文摘	Bookman MA Malmstrom H Bolis G		J Clin Oncol0，，：	1
13	Focus on epithelial ovarian cancer显示文摘	Ozols RF Bookman MA Connolly DC	2004	Cancer Cell2004，5，1：	1
14	Focus on ep- ithelial ovarian cancer显示文摘	Ozols RF Bookman MA Connolly DC	2004	Cancer Cell2004，5，1：	1
15	Topotecan for the treatment of advanced epithelial ovarian cancer: An open label phase Ⅱ study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel 显示文摘	Bookman MA Malmstrom H Bolis G	1998	J Clin Oncol1998，16，：	1
16	Incorporation of bevacizumab in the primary treatment of ovarian cancer 显示文摘	Burger RA Brady MF Bookman MA	2011	N Engl J Med2011，365，26：	1
17	Focus on epi- thelial ovarian cancer显示文摘	Ozols RF Bookman MA Connolly DC	2005	Cancer Cell2005，5，：	1
18	Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase Ⅱ study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel 显示文摘	Bookman MA Malmstrom H Boris G		J Clin Oncol0，，：	1
19	Factoring outcomes in ovarian cancer显示文摘	Bookman MA Ozols RF	1996	J Cliu Oncol1996，14，2：	1
20	Topotecan has substantial antitumor activity as first line salvage therapy in platinum sensitive epithelial ovarian carcinoma:A Gynecologic Oncology Group Study 显示文摘	McGuire WP Blessing JA Bookman MA	2000	J Clin Oncol2000，18，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示